Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion type Assertion NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_head.
- NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion description "[To investigate the level of costimulating molecules in systemic lupus erythematosus (SLE), we assessed the plasma concentrations of soluble forms of costimulatory molecules such as programmed death-1 (PD-1), B7-H1 (also called PD-L1 or CD274) and inducible costimulator ligand (ICOSL) in patients with SLE.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_provenance.
- NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion evidence source_evidence_literature NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_provenance.
- NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion SIO_000772 19395451 NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_provenance.
- NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion wasDerivedFrom befree-20140225 NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_provenance.
- NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_assertion wasGeneratedBy ECO_0000203 NP855743.RAki_r2mqbDU_fjok5x4KSg7kn8EfrEUohYK1mMZ4btAE130_provenance.